Short answer
KORU Medical Systems, Inc. (KRMD) filed its Q1 2026 10-Q quarterly report on May 6, 2026 for the quarter ended Mar 31, 2026. Quarterly revenue was $12M (up 22.1% year over year) with net income of −$807,078.
Q1 2026 key financials · XBRL
- Revenue
- $12M
- +22.1% YoY
- Net income
- −$807,078
- +30.8% YoY
- Operating margin
- -7.4%
- Gross margin
- 61.5%
- EPS (diluted)
- −$0.02
- −166.7% YoY
Source: XBRL data from the KORU Medical Systems, Inc. (KRMD) Q1 2026 10-Q on SEC EDGAR. USD.
KORU Medical Systems, Inc. Q1 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $11.8M, up 22.1% YoY from $9.6M
- Gross margin 61.5% vs 62.8% YoY; net loss $0.8M vs $1.2M
- Best segment pharma services, $0.7M revenue, up 166.0% YoY
- Operating cash flow $14,663 vs $(237,467); cash $8.8M at March 31
- Outlook: liquidity sufficient at least 12 months; tariffs, inflation, and potential financing needs remain headwinds
Risk Factors
- Carried-forward business risks referenced from the December 31, 2025 10-K
- Regulatory, legal, operational, competitive, and financial risks not detailed in the provided text
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other KORU Medical Systems, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.